Platelet interaction with polymerizing fibrin.
Interaction of washed pig, rabbit, or human platelets with fibrinogen was studied during its transition to fibrin using photometric, isotopic, and electron microscopic techniques. Untreated fibrinogen and fully polymerized fibrin had no detectable effect on platelets. Fibrinogen, incubated with low concentrations of reptilase or thrombin, formed intermediate products which readily became associated with platelets and caused their aggregation. Neutralization of the thrombin did not prevent this interaction. In the absence of fibrinogen, reptilase did not affect platelets. The interaction of polymerizing fibrin with platelets was accompanied by small losses of platelet constituents (serotonin, adenine nucleotides, platelet factor 4, and lactic dehydrogenase). This loss did not appear to be the result of the platelet release reaction. Inhibitors of the release reaction or of adenosine diphosphate (ADP)-induced aggregation did not prevent the interaction of platelets with polymerizing fibrin. Apyrase or prostaglandin E(1) (PGE(1)) reduced the extent of platelet aggregation by polymerizing fibrin, but the amount of protein associated with platelets was slightly increased. The interaction of polymerizing fibrin with platelets was completely inhibited by ethylenediaminetetraacetate (EDTA) or ethylene glycol bis (beta-aminoethyl ether) N, N,N',N'-tetraacetic acid (EGTA).Fibers formed in solutions of polymerizing fibrin were larger in the presence than in the absence of washed platelets, suggesting that platelets affect fibrin polymerization. The adherence of platelets to polymerizing fibrin may be responsible for the establishment of links between platelets and fibrin in hemostatic plugs and thrombi.
D000227:Adenine Nucleotides / Q000032:analysis; D000244:Adenosine Diphosphate / Q000037:antagonists & inhibitors; D000818:Animals; D001792:Blood Platelets / Q000032:analysis / Q000166:cytology / Q000187:drug effects*; D002417:Cattle; D002449:Cell Aggregation / Q000187:drug effects; D002614:Chelating Agents / Q000494:pharmacology; D004492:Edetic Acid / Q000494:pharmacology; D005337:Fibrin / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D005340:Fibrinogen / Q000494:pharmacology*; D006629:Hirudins / Q000494:pharmacology; D006801:Humans; D007456:Iodine Isotopes; D007531:Isoflurophate / Q000494:pharmacology; D007770:L-Lactate Dehydrogenase / Q000032:analysis; D008854:Microscopy, Electron; D010973:Platelet Adhesiveness / Q000187:drug effects*; D011108:Polymers / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology; D011817:Rabbits; D012701:Serotonin / Q000378:metabolism; D013552:Swine; D013917:Thrombin / Q000037:antagonists & inhibitors / Q000494:pharmacology; D014316:Tritium
D000227:Adenine Nucleotides; D002614:Chelating Agents; D006629:Hirudins; D007456:Iodine Isotopes; D011108:Polymers; D011453:Prostaglandins; D014316:Tritium; D007531:Isoflurophate; D012701:Serotonin; D000244:Adenosine Diphosphate; D005337:Fibrin; D005340:Fibrinogen; D004492:Edetic Acid; D007770:L-Lactate Dehydrogenase; D013917:Thrombin